Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

Author:

Takahashi Koichi123ORCID,Hu Boyu4,Wang Feng2,Yan Yuanqing5,Kim Ekaterina1,Vitale Candida1,Patel Keyur P.6,Strati Paolo4,Gumbs Curtis2,Little Latasha2,Tippen Samantha2,Song Xingzhi7,Zhang Jianhua2,Jain Nitin1,Thompson Philip1,Garcia-Manero Guillermo1,Kantarjian Hagop1,Estrov Zeev1,Do Kim-Anh5,Keating Michael1,Burger Jan A.1,Wierda William G.1,Futreal P. Andrew2,Ferrajoli Alessandra1

Affiliation:

1. Department of Leukemia and

2. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;

3. Department of Hematology and Oncology, Kyoto University School of Medicine, Kyoto, Japan; and

4. Division of Cancer Medicine,

5. Department of Biostatistics,

6. Department of Hematopathology, and

7. Applied Cancer Science Institute, The University of Texas MD Anderson Cancer Center, Houston, TX

Abstract

Key Points Cancer gene mutations affect treatment response and survival in patients with CLL treated with lenalidomide. The assessment of cancer gene mutations may be useful in the risk stratification of CLL patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3